Abstract
IntroductionDespite repeated vaccinations against SARS-CoV-2 virus, patients who are immunocompromised remain at very high risk of catching SARS-CoV-2 virus and becoming unwell. AZD7442 (Evusheld) is a long-acting monoclonal antibody treatment...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have